NEUTRALIZATION ESCAPE MUTANTS OF TYPE-A INFLUENZA-VIRUS ARE READILY SELECTED BY ANTISERA FROM MICE IMMUNIZED WITH WHOLE VIRUS - A POSSIBLE MECHANISM FOR ANTIGENIC DRIFT

被引:58
作者
LAMBKIN, R [1 ]
MCLAIN, L [1 ]
JONES, SE [1 ]
ALDRIDGE, SL [1 ]
DIMMOCK, NJ [1 ]
机构
[1] UNIV WARWICK,DEPT BIOL SCI,COVENTRY CV4 7AL,W MIDLANDS,ENGLAND
关键词
D O I
10.1099/0022-1317-75-12-3493
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
It is not fully understood how antigenic drift of the haemagglutinin of type A influenza virus in man occurs in the presence of the expected polyclonal antibody response to the five antigenic sites, A to E. Here we show that 12 % (11/92) of sera from mice which had mounted a secondary immune response to inactivated influenza virus were able to select escape mutants. No escape mutant was selected with serum from nonimmunized mice (0/65). Selection required only a single passage, and escape mutants were identified by their reaction with monoclonal antibodies (MAbs); all but one had altered reactivity at site A. Most of the site A escape mutants (7/10) were conventional in character and did not react in haemagglutination-inhibition (HI) or neutralization assays with the identifying MAb. The HA genes of three of these were part sequenced and had a predicted single amino acid substitution (Gly-144 --> Glu) in site A. The other escape mutants (3/10) had a small (2-fold) reduction in HI and neutralization to the site A MAb, but no amino acid substitution in site A. The final mutant was a conventional site B escape mutant. To model antisera which selected escape mutants, we constructed 'pseudo-immune sera' using mixtures of two neutralizing MAbs in which the first MAb was held at a constant high concentration (1000 HIU/ml). Escape mutants could be selected to the first MAb when the titre of the second MAb was reduced to a low but still inhibiting concentration (1 to 3 HIU/ml). Mixtures of three MAbs also selected escape mutants with similar facility provided that the second and third MAbs were reduced to a similar low concentration. Thus it is possible that the ability of an antiserum to select escape mutants is due to the neutralizing antibody response being biased to an epitope/cross-reacting epitopes within a single antigenic site. However, when escape mutants were reacted in HI assay with their selecting antiserum, the maximum difference from the titre with wt virus was 75 %. The findings of this study may be relevant to the understanding of antigenic drift in type A human influenza virus, and to immune-driven antigenic variation in other virus infections.
引用
收藏
页码:3493 / 3502
页数:10
相关论文
共 52 条
[1]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[2]   PERSISTENT ANTIGENIC VARIATION OF INFLUENZA A VIRUSES AFTER INCOMPLETE NEUTRALIZATION IN OVO WITH HETEROLOGOUS IMMUNE SERUM [J].
ARCHETTI, I ;
HORSFALL, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1950, 92 (05) :441-462
[3]   NEUTRALIZING ANTIBODY-RESPONSE DURING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - TYPE AND GROUP SPECIFICITY AND VIRAL ESCAPE [J].
ARENDRUP, M ;
SONNERBORG, A ;
SVENNERHOLM, B ;
AKERBLOM, L ;
NIELSEN, C ;
CLAUSEN, H ;
OLOFSSON, S ;
NIELSEN, JO ;
HANSEN, JES .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :855-863
[4]  
ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303
[5]   AN ANALYSIS OF THE PROPERTIES OF MONOCLONAL-ANTIBODIES DIRECTED TO EPITOPES ON INFLUENZA-VIRUS HEMAGGLUTININ [J].
BROWN, LE ;
MURRAY, JM ;
WHITE, DO ;
JACKSON, DC .
ARCHIVES OF VIROLOGY, 1990, 114 (1-2) :1-26
[6]   VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS [J].
CARMAN, WF ;
ZANETTI, AR ;
KARAYIANNIS, P ;
WATERS, J ;
MANZILLO, G ;
TANZI, E ;
ZUCKERMAN, AJ ;
THOMAS, HC .
LANCET, 1990, 336 (8711) :325-329
[7]  
CLARKE SH, 1990, J IMMUNOL, V144, P2795
[8]  
DESTGROTH SF, 1978, TOPICS INFECT DIS, V3, P25
[9]  
DIMMOCK NJ, 1993, CURR TOP MICROBIOL, V183, P1
[10]  
HAAHEIM LR, 1980, ACTA PATH MICRO IM B, V88, P351